Approval · Notice of Compliance 17044 · 2015
APO-DEXTROAMPHETAMINE: Notice of Compliance 17044
Issued June 30, 2015
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 17044
- Date
- June 30, 2015
- Company
- Apotex Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Sympathomimetic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| APO-DEXTROAMPHETAMINE | 02443236 | Marketed |
Medicinal ingredients
- DEXTROAMPHETAMINE SULFATE 5 MG per TAB